Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandra Negro

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Progress in Pediatric Cardiology|April 4, 2009
Signalosomes as Therapeutic TargetsAlejandra Negro, Kimberly Dodge-Kafka, Michael S Kapiloff
Recent Progress in Hormone Research|January 30, 2004
Essential roles of Her2/erbB2 in cardiac development and functionAlejandra Negro, Bhawanjit K Brar, Kuo-Fen Lee
Neuron|January 16, 2003
Colonic epithelial expression of ErbB2 is required for postnatal maintenance of the enteric nervous systemSteven A Crone, Alejandra Negro, Andreas Trumpp, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2006
erbB2 is required for G protein-coupled receptor signaling in the heartAlejandra Negro, Bhawanjit K Brar, Yusu Gu, et al.
Journal of Molecular and Cellular Cardiology|November 4, 2009
The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurinJinliang Li, Alejandra Negro, Johanna Lopez, et al.
Journal for Immunotherapy of Cancer|May 30, 2025
Differential safety profiles of durvalumab monotherapy and durvalumab in combination with tremelimumab in adult patients with advanced cancersClaire Morgan, John Kurland, Mayur Patel, et al.
Journal of Clinical Pharmacology|June 10, 2023
Population Pharmacokinetics and Exposure-Response Analysis of Tremelimumab 300 mg Single Dose Combined with Durvalumab 1500 mg Q4W (STRIDE) in Patients with Unresectable Hepatocellular CarcinomaKyoungSoo Lim, Aburough Abegesah, Chunling Fan, et al.
Endocrinology|September 13, 2003
Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heartBhawanjit K Brar, Anne K Jonassen, Elena M Egorina, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 11, 2021
Understanding the patient experience in hepatocellular carcinoma: a qualitative patient interview studyNikunj Patel, Joshua Maher, Xandra Lie, et al.
Future Oncology (London, England)|May 10, 2022
MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancerYelena Y Janjigian, Eric Van Cutsem, Kei Muro, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Progress in Pediatric Cardiology|April 4, 2009
Signalosomes as Therapeutic TargetsAlejandra Negro, Kimberly Dodge-Kafka, Michael S Kapiloff
Recent Progress in Hormone Research|January 30, 2004
Essential roles of Her2/erbB2 in cardiac development and functionAlejandra Negro, Bhawanjit K Brar, Kuo-Fen Lee
Neuron|January 16, 2003
Colonic epithelial expression of ErbB2 is required for postnatal maintenance of the enteric nervous systemSteven A Crone, Alejandra Negro, Andreas Trumpp, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 18, 2006
erbB2 is required for G protein-coupled receptor signaling in the heartAlejandra Negro, Bhawanjit K Brar, Yusu Gu, et al.
Journal of Molecular and Cellular Cardiology|November 4, 2009
The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurinJinliang Li, Alejandra Negro, Johanna Lopez, et al.
Journal for Immunotherapy of Cancer|May 30, 2025
Differential safety profiles of durvalumab monotherapy and durvalumab in combination with tremelimumab in adult patients with advanced cancersClaire Morgan, John Kurland, Mayur Patel, et al.
Journal of Clinical Pharmacology|June 10, 2023
Population Pharmacokinetics and Exposure-Response Analysis of Tremelimumab 300 mg Single Dose Combined with Durvalumab 1500 mg Q4W (STRIDE) in Patients with Unresectable Hepatocellular CarcinomaKyoungSoo Lim, Aburough Abegesah, Chunling Fan, et al.
Endocrinology|September 13, 2003
Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heartBhawanjit K Brar, Anne K Jonassen, Elena M Egorina, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 11, 2021
Understanding the patient experience in hepatocellular carcinoma: a qualitative patient interview studyNikunj Patel, Joshua Maher, Xandra Lie, et al.
Future Oncology (London, England)|May 10, 2022
MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancerYelena Y Janjigian, Eric Van Cutsem, Kei Muro, et al.
Pageof 3